Gennex Laboratories Share Price

BSE
GENNEX •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Gennex Laboratories
Gennex Laboratories Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Gennex Laboratories Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
55.38% Fall from 52W High
-4
Dividend yield 1yr %
0

Gennex Laboratories Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Gennex Laboratories Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
40.01 Cr
31.55 Cr
28.32 Cr
33.5 Cr
19.14 Cr

Gennex Laboratories Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
91.62 Cr
69.56 Cr
62.6 Cr
60.17 Cr
56.57 Cr
56.59 Cr

Gennex Laboratories Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
5.07 Cr
5.37 Cr
4.66 Cr
4.5 Cr
2.76 Cr

Gennex Laboratories Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
13.18 Cr
4.92 Cr
3.92 Cr
4.04 Cr
1.86 Cr
2.22 Cr

Gennex Laboratories shareholding Pattern

Promoter
18.4%
Public
81.6%
Promoter
18.4%
Public
81.6%
Promoter
18.4%
Public
81.6%
Promoter
18.4%
Public
81.6%
Promoter
18.4%
Public
81.6%
Promoter
23.6%
Public
76.4%

Gennex Laboratories Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
13.40
10Day EMA
13.50
12Day EMA
13.50
20Day EMA
13.40
26Day EMA
13.40
50Day EMA
13.80
100Day EMA
14.80
200Day EMA
15.70
5Day SMA
13.60
10Day SMA
13.50
20Day SMA
13.20
30Day SMA
13.50
50Day SMA
13.30
100Day SMA
14.80
150Day SMA
17.10
200Day SMA
17.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
252048 Rs
326843 Rs
Week Rs
256866 Rs
353169 Rs
Month Rs
319553 Rs
445463 Rs
Resistance & Support
13.16
Pivot
Resistance
First Resistance
13.31
Second Resistance
13.51
Third Resistance
13.66
Support
First Support
12.96
Second support
12.81
Third Support
12.61
Relative Strength Index
46.19
Money Flow Index
44.96
MACD
0.01
MACD Signal
0
Average True Range
0.79
Average Directional Index
12.03
Rate of Change (21)
-6.69
Rate of Change (125)
-39.68

Gennex Laboratories Latest News

22 APR 2025 | Tuesday

Gennex Laboratories Ltd - 531739 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

26 MAR 2025 | Wednesday

Gennex Laboratories Ltd - 531739 - Closure of Trading Window

24 MAR 2025 | Monday

Gennex Laboratories Ltd - 531739 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

View More

Gennex Laboratories Company background

Founded in: 1990
Managing director: Arihant Baid
Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985. The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007.The Company is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates. It is engaged in manufacturing and marketing of bulk drugs and intermediates. Gennex is among the leading Vertically Integrated pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal. The company thrives on the strength of its exports to various countries viz. Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and Others. The Companys factory is situated at Andhra Pradesh, India. The company has a professionally managed team at every stage of its operations.During the year 20052006, the company implemented GMP (Good Manufacturing Practices). In 200607, it installed Separate Air Handling System in final drug isolation area and also in drying and packing area. Also, it implemented the CGMP in manufacturing area as per ICH WHO Guidelines. In 20072008, it diversified into the business of Biotech product. The Company acquired 51% shareholding in Deccan Remedies Limited and thus became the subsidiary of the Company in 2023.
Read More

Gennex Laboratories FAQs

You can easily buy Gennex Laboratories shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Gennex Laboratories stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -